(一)教材书籍:
1. 詹思延主编, 流行病学(第8版). 北京: 人民卫生出版社. 2017.
2. 段广才主编, 流行病学实习教程. 北京:人民卫生出版社. 2011.
(二)参考文献:
1. McBride W G. The teratogenic action of drugs[J]. Medical Journal of Australia, 1963, 2(17): 689-693.
2. Smithells R W, Leck I. The incidence of limb and ear defects since the withdrawal of thalidomide[J]. The Lancet, 1963, 281(7290): 1095-1097.
3. Hausen H Z, Meinhof W, Scheiber W, et al. Attempts to detect virus‐specific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus[J]. International journal of cancer, 1974, 13(5): 650-656.
4. Rozendaal L, Walboomers J M M, Van Der Linden J C, et al. PCR‐based high‐risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears[J]. International journal of cancer, 1996, 68(6): 766-769.
5. Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study[J]. The Lancet infectious diseases, 2014, 14(4): 308-318.
6. Zhu F C, Meng F Y, Li J X, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial[J]. The Lancet, 2013, 381(9882): 2024-2032.
7. Li R, Liu L, Mo Z, et al. An inactivated enterovirus 71 vaccine in healthy children[J]. New England Journal of Medicine, 2014, 370(9): 829-837.
8. Report of an International Commission (1978). Ebola haemorrhagic fever in Zaire, 1976. Bulletin of the World Health Organization, 56(2), 271–293.
9. Smith C E G, Simpson D I H, Bowen E T W, et al. Fatal human disease from vervet monkeys[J]. The Lancet, 1967, 290(7526): 1119-1121.
10. Gire S K, Goba A, Andersen K G, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak[J]. science, 2014, 345(6202): 1369-1372.
11. Zhu F C, Wurie A H, Hou L H, et al. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial[J]. The Lancet, 2017, 389(10069): 621-628.
12. Agnandji S T, Huttner A, Zinser M E, et al. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe[J]. New England Journal of Medicine, 2016, 374(17): 1647-1660.
13. 吴朝仁, 连志浩, 陈文俊, 等. 肉毒中毒—“察布查尔病”的调查报告[J]. 中华医学杂志,1958,44(10): 932-938.
14. Liao G, Li R, Li C, et al. Phase 3 Trial of a Sabin Strain–Based Inactivated Poliovirus Vaccine[J]. The Journal of infectious diseases, 2016, 214(11): 1728-1734.
15. Meldrum M. “A calculated risk”: the Salk polio vaccine field trials of 1954[J]. BMJ, 1998, 317(7167): 1233-1236.
16. Snow J. The mode of propagation of cholera[J]. Association medical journal, 1856, 4(163): 135.
17. Zuckerman J N, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control[J]. The Lancet infectious diseases, 2007, 7(8): 521-530.
18. 胡善联, 胡时豪, 苏竹君, 等. 上海甲肝流行与卫生防疫管理[J]. 中国公共卫生管理, 1989 (2): 13-16.
19. Zhang H W, Yin J H, Li Y T, et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China[J]. Gut, 2008, 57(12): 1713-1720.
20. Wu V C, Huang J W, Lien H C, et al. Levamisole-induced multifocal inflammatory leukoencephalopathy: clinical characteristics, outcome, and impact of treatment in 31 patients[J]. Medicine, 2006, 85(4): 203-213.
21. Guo-quan L I U H J I A, Xin S H I. Analysis of ADR of Acute Disseminated Encephalomyelitis Caused by Levamisole Therapy[J]. Anti-Infection Pharmacy, 2007, 4.
22. Lucia P, Pocek M, Passacantando A, et al. Multifocal leucoencephalopathy induced by levamisole[J]. The Lancet, 1996, 348(9039): 1450.
23. Maclagan T. The treatment of acute rheumatism by salicin[J]. The Lancet, 1876, 108(2774): 601-604.
24. Elwood P C, Cochrane A L, Burr M L, et al. A randomized controlled trial of acetyl salicyclic acid in the secondary prevention of mortality from myocardial infarction[J]. Br Med J, 1974, 1(5905): 436-440.
25. Qin C, Lv J, Guo Y, et al. Associations of egg consumption with cardiovascular disease in a cohort study of 0.5 million Chinese adults[J]. Heart, 2018, 104(21): 1756-1763.
26. Parsonnet J, Friedman G D, Vandersteen D P, et al. Helicobacter pylori infection and the risk of gastric carcinoma[J]. New England Journal of Medicine, 1991, 325(16): 1127-1131.
27. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer[J]. New England Journal of Medicine, 2001, 345(11): 784-789.
28. Xu Z Y, Liu C B, Francis D P, et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial[J]. Pediatrics, 1985, 76(5): 713-718.
29. Xu D Z, Wang X Y, Shen X L, et al. Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings[J]. Journal of hepatology, 2013, 59(3): 450-456.
30. Lin C H, Jeng J S, Hsieh S T, et al. Acute disseminated encephalomyelitis: a follow-up study in Taiwan[J]. Journal of Neurology, Neurosurgery & Psychiatry, 2007, 78(2): 162-167.
31. Ghofrani H A, Morrell N W, Hoeper M M, et al. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy[J]. American journal of respiratory and critical care medicine, 2010, 182(9): 1171-1177.
32. Robertson K A, Nalepa G, Yang F C, et al. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial[J]. The lancet oncology, 2012, 13(12): 1218-1224.
33. Robertson K A, Nalepa G, Yang F C, et al. Pilot phase II trial of imatinib mesylate in neurofibromatosis type 1 patients with plexiform neurofibromas[J]. The Lancet. Oncology, 2012, 13(12): 1218.
34. Pun V C, Kazemiparkouhi F, Manjourides J, et al. Long-term PM2. 5 exposure and respiratory, cancer, and cardiovascular mortality in older US adults[J]. American journal of epidemiology, 2017, 186(8): 961-969.
35. Liang F, Yang X, Liu F, et al. Long-term exposure to ambient fine particulate matter and incidence of diabetes in China: A cohort study[J]. Environment international, 2019, 126: 568-575.